Rani Therapeutics Holdings (RANI) Retained Earnings (2020 - 2025)
Historic Retained Earnings for Rani Therapeutics Holdings (RANI) over the last 6 years, with Q3 2025 value amounting to -$122.3 million.
- Rani Therapeutics Holdings' Retained Earnings fell 3010.64% to -$122.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$122.3 million, marking a year-over-year decrease of 3010.64%. This contributed to the annual value of -$102.9 million for FY2024, which is 4118.32% down from last year.
- Latest data reveals that Rani Therapeutics Holdings reported Retained Earnings of -$122.3 million as of Q3 2025, which was down 3010.64% from -$116.9 million recorded in Q2 2025.
- Over the past 5 years, Rani Therapeutics Holdings' Retained Earnings peaked at -$3.1 million during Q3 2021, and registered a low of -$125.1 million during Q2 2021.
- Moreover, its 5-year median value for Retained Earnings was -$69.3 million (2023), whereas its average is -$66.6 million.
- As far as peak fluctuations go, Rani Therapeutics Holdings' Retained Earnings surged by 9269.23% in 2021, and later crashed by 85903.88% in 2022.
- Quarter analysis of 5 years shows Rani Therapeutics Holdings' Retained Earnings stood at -$8.3 million in 2021, then tumbled by 367.16% to -$38.9 million in 2022, then tumbled by 87.28% to -$72.9 million in 2023, then crashed by 41.18% to -$102.9 million in 2024, then fell by 18.85% to -$122.3 million in 2025.
- Its Retained Earnings stands at -$122.3 million for Q3 2025, versus -$116.9 million for Q2 2025 and -$110.2 million for Q1 2025.